EUVIMEDEUVIMED entdecken
Crossref

METTL14 Promotes HK-2 Cell Injury in Diabetic Nephropathy Through the Regulation of THBS2 Expression in an m6A-YTHDF2-Dependent Manner

Qingqing Zhang, Yinglu Zhao, Wen Cao, Shaofei Wang, Weipeng Fan iD

Experimental and Clinical Endocrinology & Diabetes · 01.08.2025 · 133 (08) · 397-407

DOI: 10.1055/a-2625-6822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.08.2025. Verfasst von Qingqing Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Hospital of Traditional Chinese Medicine, Xi'an, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Methyltransferases, Thrombospondins, RNA Splicing Factors. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To explore how methyltransferase like 14 (METTL14) regulates diabetic nephropathy (DN)-induced cell damage and analyze its underlying mechanisms. The gene expression data were obtained from the Gene Expression Omnibus (GEO) database and analyzed for differential expression using the DESeq2 package. The gene expression levels were detected by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting. Cell proliferation and apoptosis were examined through cell counting kit-8 (CCK8) and flow cytometry, respectively. The levels of inflammatory cytokines (interleukin-6 [IL-6], IL-8, and tumor necrosis factor-alpha (TNF-α)) were determined through enzyme-linked immunosorbent assay (ELISA). Levels of ferroptosis indicators, including reactive oxygen species (ROS), malondialdehyde (MDA), glutathione (GSH), and ferrous iron (Fe²+), were measured using dedicated kits. The m6A modification of mRNA was predicted by the Sequence-based RNA Adenosine Methylation Site Predictor (SRAMP) database and was validated using RNA immunoprecipitation (RIP) assay. The m6A RIP-qPCR was performed to verify the interaction of thrombospondin-2 (THBS2) with METTL14 or YTHN6-methyladenosine RNA binding protein 2 (YTHDF2). THBS2 was highly expressed in both DN patients and high glucose (HG)-induced HK-2 cells. THBS2 silencing promoted HG-induced HK-2 cell proliferation and decreased apoptosis, fibrosis, inflammation, and ferroptosis. METTL14 stabilized THBS2 in an m6A-YTHDF2-mediated manner. Suppression of METTL14 expression could alleviate the HG-induced damage to HK-2 cells. THBS2 overexpression negated the protective effects of METTL14 knockdown in HK-2 cells.Conclusions: METTL14 exacerbates HG-induced damage in HK-2 cells by modulating THBS2 expression in an m6A-YTHDF2-dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesMethyltransferasesThrombospondinsRNA Splicing FactorsKidney Tubules, ProximalRNA-Binding ProteinsGene Expression RegulationHumansCell LineApoptosisAdenosineCell ProliferationThrombospondin 2

Substanzen

MethyltransferasesThrombospondinsRNA Splicing FactorsRNA-Binding ProteinsAdenosineThrombospondin 2METTL14 protein, humanYTHDF2 protein, human

Autor:innen und Institutionen

  • Xi'an Hospital of Traditional Chinese Medicine, Xi'an, China.
  • Affiliated Hospital of Shaanxi University of Chinese Medicine, Xi'an, China.

ORCID-Profile: Weipeng Fan

Zitieren

APA

Zhang, Q., Zhao, Y., Cao, W., Wang, S., & Fan, W. (2025). METTL14 Promotes HK-2 Cell Injury in Diabetic Nephropathy Through the Regulation of THBS2 Expression in an m6A-YTHDF2-Dependent Manner. Experimental and Clinical Endocrinology & Diabetes, 133(08), 397-407. https://doi.org/10.1055/a-2625-6822

Vancouver

Zhang Q, Zhao Y, Cao W, Wang S, Fan W. METTL14 Promotes HK-2 Cell Injury in Diabetic Nephropathy Through the Regulation of THBS2 Expression in an m6A-YTHDF2-Dependent Manner. Experimental and Clinical Endocrinology & Diabetes. 2025;133(08):397-407. doi:10.1055/a-2625-6822

BibTeX
@article{Zhang2025,
  author = {Zhang, Qingqing and Zhao, Yinglu and Cao, Wen and Wang, Shaofei and Fan, Weipeng},
  title = {METTL14 Promotes HK-2 Cell Injury in Diabetic Nephropathy Through the Regulation of THBS2 Expression in an m6A-YTHDF2-Dependent Manner},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2025},
  volume = {133},
  number = {08},
  pages = {397--407},
  doi = {10.1055/a-2625-6822}
}
Kostenlos starten →